HOME >> BIOLOGY >> NEWS
Wiley-VCH and EFIS expand collaboration

September 18, 2006, Weinheim, Germany -- Wiley-VCH Verlag, the Executive Committee (ExCo) of the European Journal of Immunology (EJI), and the European Federation of Immunological Societies (EFIS) announced today that they have entered into an expanded new publishing agreement, designed to make the European Journal of Immunology the foremost international immunology journal published in Europe. Edited under the auspices of EFIS, EJI will focus on publishing a broad spectrum of high-quality scientific research from around the world.

On a rotating basis, new editors representing the range of subject fields covered in the journal will be jointly invited by EFIS and Wiley-VCH to serve as ExCo members of the journal with the aim of ensuring a rapid and high standard peer-review of submitted papers. Professor Rolf Zinkernagel, who has served as Chair of the ExCo with distinction and enthusiasm over the past seven years, will continue his work for the journal until the end of 2007. He will be supported by two deputies, to be appointed shortly, one from the U.S. and one from Australasia/Asia.

"This is a new beginning, one that we all look forward to with great enthusiasm" said Professor Foo Yoo Liew, Past-President of EFIS.

Stefan H. E. Kaufmann, the new President of EFIS, is excited about the tremendous opportunities that arise through this agreement: "All aspects of European immunology including education, public awareness and science will benefit enormously from this arrangement."

"The real winner of this new collaboration agreement is the scientific community, as profits from the journal will be used to aid and support the immunology research community and to sponsor scientific events," said Dr. Manfred Antoni, Managing Director of Wiley-VCH. All such charitable activities will be administered by EFIS and will be publicly announced in the journal and in EFIS communications.


'"/>

Contact: Dr. Cate Livingstone
Clivings@wiley-vch.de
49-062-016-06449
John Wiley & Sons, Inc.
18-Sep-2006


Page: 1

Related biology news :

1. EMBL expands to Australia
2. Genomatix expands operations in North America
3. PET/CT use expands: Effectively diagnosing graft infections
4. Salmon tracking program expands to California
5. Wilson Center and Pew Charitable Trusts expand efforts to examine risks/benefits of nanotechnology
6. Scientists expand microbe gene language
7. ResearchChannel expands delivery for its extensive online video library
8. Lehigh scientist receives NHGRI grant to streamline, expand use of genome sequencing
9. Springer expands life science program with In Vitro journals
10. Male contraceptive study expands to 4 US cities
11. $20 million to expand seafloor observatory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... 25, 2020 , ... Modality Solutions, a biopharmaceutical cold chain validation ... list. The list is the most prestigious ranking of the nation’s fastest-growing private companies. ... year’s list, reported three-year revenue growth of 71 percent. , The Inc. 5000 ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners ... a Clinical Operations executive with expertise in clinical trial planning and feasibility, regulatory ... an Expert Consultant. Throughout his career, Mr. Movahhed has helped design and manage ...
(Date:8/5/2020)... , ... August 05, 2020 , ... Regenative Labs has ... new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be ... a syringe. The company’s solutions are the first Wharton’s jelly allograft product to be ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... PORTLAND, Ore. (PRWEB) , ... August 13, 2020 , ... ... announced the creation of its Scientific Advisory Board (SAB) to research the medical ... medical cannabis can be enhanced when combined with terpenes. The board is focused on ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... validation engineering firm, is making available for free its new white paper ... concurrent transport simulation testing into today’s biologics licensing application (BLA). In response, ...
(Date:8/3/2020)... ... , ... ERT, the global leader in clinical ... one of the 100 most inspiring individuals in the life-sciences industry by PharmaVoice. ... on how they have inspired their colleagues and affected positive changes in their ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader in ... “BUILDING FOR LIFE.” The adoption of this taglines comes at a time of ... capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. ...
Breaking Biology Technology:
Cached News: